ClinicalTrials.gg
RecruitingNCT03845036Updated Apr 17, 2026

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

An interventional study of DASH Diet plus Home-Based Exercise and Home-Based Exercise in Claudication and Peripheral Artery Disease, sponsored by University of Oklahoma. Recruiting at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-04-17.

Sponsored by University of Oklahoma · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.

Read the detailed description

This study seeks to (1) compare the changes in 6-minute walk distance (6MWD) and physical function quality of life in patients with peripheral artery disease (PAD) following a combined intervention of the dietary approaches to stop hypertension (DASH) dietary program plus a home-based exercise program, and following a home-based exercise program alone; and (2) compare the changes in microvascular function and inflammation in patients following the combined DASH diet and home-based exercise program, and the home-based exercise program alone.

The investigators hypothesize that the combined DASH diet and exercise program will result in greater increases in 6MWD and in the physical function quality of life than the exercise program alone. Further, it is hypothesized that the combined DASH diet and exercise program will result in greater improvements in calf muscle oxygen saturation [StO2] following exercise, and in high-sensitivity C-reactive protein (hsCRP]) than the exercise program alone.

The home-based exercise program consists of intermittent walking to moderate claudication pain in a home-based setting. The DASH dietary program consists of the dietary approaches to stop hypertension diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy.

02

Conditions studied

  • Claudication
  • Peripheral Artery Disease
03

In context

Intermittent Claudication

309 studies on the registry are indexed under Intermittent Claudication; 46 are open to participants now.

This study's planned enrollment of 150 is above the median of 74 across 242 interventional studies indexed under Intermittent Claudication.

Browse Intermittent Claudication studies →

Lead sponsor

University of Oklahoma is the lead sponsor of 432 studies on the registry; 100 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 16 (38%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. History of claudication,
  2. Presence of PAD, defined by meeting at least one of the following criteria (ABI at rest \< 0.90, or > 20% decrease in ABI following a heel-rise exercise test in patients with a normal ABI at rest (> 0.90), or history of peripheral revascularization.

Exclusion criteria

Exclusion Criteria:

  1. absence of PAD, defined by meeting all of the following 3 criteria (ABI at rest > 0.90), \< 20% decrease in ABI following a heel-rise exercise test, and no history of peripheral revascularization,
  2. non-compressible vessels (ABI > 1.40),
  3. rest pain due to PAD (Fontaine stage III; Rutherford Grade II),
  4. tissue loss due to PAD (Fontaine stage IV; Rutherford Grade III),
  5. use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation,
  6. peripheral revascularization within one month prior to investigation,
  7. active cancer,
  8. end stage renal disease defined as stage 5 chronic kidney disease,
  9. medical conditions that are contraindicative for exercise according to the American College of Sports Medicine,
  10. cognitive dysfunction ( score \< 24), and
  11. failure to complete the baseline tests within three weeks.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    DASH Diet plus Home-Based Exercise

    The DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

    Behavioral: DASH Diet plus Home-Based Exercise

  • Active comparator
    Home-Based Exercise

    The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

    Behavioral: Home-Based Exercise

Interventions

  • BehavioralDASH Diet plus Home-Based Exercise

    The DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

  • BehavioralHome-Based Exercise

    The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

06

What researchers measure

Primary outcomes

  1. Peak Walking Time

    The change in the time walked on a treadmill test

    Time frame: 3 months

  2. Physical Function subscale of quality of life from the Medical Outcomes Study Short-Form 36 questionnaire

    The change in the Physical Function subscale from the pre-test value to the post-test value

    Time frame: 3 months

Secondary outcomes

  1. calf muscle oxygen saturation

    The change in the calf muscle oxygen saturation value during exercise from the pre-test value to the post-test value

    Time frame: 3 months

  2. 6-minute walk distance

    The change in 6-minute walk distance from the pre-test value to the post-test value

    Time frame: 3 months

  3. high-sensitivity C-reactive protein

    The change in the high-sensitivity C-reactive protein value from the pre-test value to the post-test value

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011 Feb 8;123(5):491-8. doi: 10.1161/CIRCULATIONAHA.110.963066. Epub 2011 Jan 24. PubMed 21262997 ↗
  • Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc. 2014 Sep 18;3(5):e001107. doi: 10.1161/JAHA.114.001107. PubMed 25237048 ↗
  • Gardner AW, Bright BC, Ort KA, Montgomery PS. Dietary intake of participants with peripheral artery disease and claudication. Angiology. 2011 Apr;62(3):270-5. doi: 10.1177/0003319710384395. PubMed 21406424 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03845036
Responsible party
Sponsor
First posted
Feb 19, 2019
Start date
Sep 16, 2024
Primary completion
May 31, 2029 (estimated)
Completion
May 31, 2029 (estimated)
Last update
Apr 17, 2026

Study contacts

Andrew Gardner, Ph.D.
Contact
andrew-gardner@ouhsc.edu
405-271-4742
Andrew Gardner, Ph.D.
principal investigator · Professor, Department of Medicine, Cardiology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion